Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China

Ying Wu; Bin Pan; Yutong Li; Jinai He; Guohua Huang; Qiufeng Li

doi:doi:10.11648/j.ajbls.20200802.13

| Peer-Reviewed

Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China

Ying Wu, Bin Pan, Yutong Li, Jinai He, Guohua Huang, Qiufeng Li

Published in American Journal of Biomedical and Life Sciences (Volume 8, Issue 2)

Received: 31 March 2020 Accepted: 13 April 2020 Published: 23 April 2020

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.

Published in	American Journal of Biomedical and Life Sciences (Volume 8, Issue 2)
DOI	10.11648/j.ajbls.20200802.13
Page(s)	41-46
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

COVID-19, Symptom, Transmission, Quarantine, Health Education, Psychological Crisis Intervention

References

[1]	Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020, 382 (8): 727-733.
[2]	Huang CL, Wang YM, Li XW, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395 (10223): 497-506.
[3]	Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 Feb 7. doi: 10.1097/CM9.0000000000000744. [Epub ahead of print].
[4]	Interim infection prevention and control recommendations for patients with known or patients under investigation for 2019 novel coronavirus (2019-nCoV) in a healthcare setting. https://www.cdc.gov/coron avirus/2019-nCoV/hcp/infec tion-contr ol.html. Accessed 30 Jan 2020.
[5]	Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011, 81: 85-64.
[6]	Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019; 11 (1) pii: E59.
[7]	Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395 (10223): 507-513.
[8]	She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020, 9 (1): 19.
[9]	Li Q, Guan XH, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus infected pneumonia. N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMoa2001316. [Epub ahead of print].
[10]	Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importati on and human-to human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020, 382 (9): 872-874.
[11]	Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China. Cell Discov. 2020, 6: 10.
[12]	New features of novel coronavirus (2019-nCoV) pneumonia. https://new. qq.com/omn/20200128/20200128A07H4S00.html. Accessed 30 Jan 2020.
[13]	Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China-Key Questions for Impact Assessment. N Engl J Med. 2020, 382 (8): 692-694.
[14]	WHO statement regarding cluster of pneumonia cases in Wuhan, China. https://www.who.int/china/news/detail/09- 01-2020-who-state.
[15]	Chen ZL, Zhang Q, Lu Y, Guo ZM, Zhang X, Zhang WJ, et al. Distribution of the COVID-19 epidemic and correlation with population emigration from wuhan, China. Chin Med J (Engl). 2020 Feb 28. doi: 10.1097/CM9.0000000000000782. [Epub ahead of print].
[16]	Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020, 395 (10225): 689-697.
[17]	Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020, 395 (10223): 514-523.
[18]	Cao Y, Li Q, Chen J, Guo X, Miao C, Yang H, Chen Z, Li C. Hospital Emergency Management Plan During the COVID-19 Epidemic. Acad Emerg Med. 2020, Mar 2. doi: 10.1111/acem.13951.[Epub ahead of print].
[19]	Chen Q, Liang M, Li Y, Guo J, Fei D, Wang L, He L, Sheng C, Cai Y, Li X, Wang J, Zhang Z. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry. 2020, 18pii: S2215-0366 (20) 30078-X.
[20]	Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020, 22. pii: dyaa033. doi: 10.1093/ije/dyaa033. [Epub ahead of print].
[21]	Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Xiang YT. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020, 18, pii: S2215-0366 (20) 30079-1. doi: 10.1016/S2215-0366(20)30079-1. [Epub ahead of print].
[22]	Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, et al. The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk. Can J Psychiatry 2009; 54 (5): 302-11.
[23]	Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.Int J Antimicrob Agents. 2020 Feb 17: 105924. doi: 10.1016/j.ijantimicag.2020.105924. [Epub ahead of print].
[24]	National Health Commission of the People’s Republic of China. Diagnosis and treatment of new coronavirus pneumonia (version 5) http://www.nhc.gov.cn/. Accessed 30 Jan 2020.

Cite This Article

Plain Text BibTeX RIS

APA Style

Ying Wu, Bin Pan, Yutong Li, Jinai He, Guohua Huang, et al. (2020). Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. American Journal of Biomedical and Life Sciences, 8(2), 41-46. https://doi.org/10.11648/j.ajbls.20200802.13

Copy | Download

ACS Style

Ying Wu; Bin Pan; Yutong Li; Jinai He; Guohua Huang, et al. Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. Am. J. Biomed. Life Sci. 2020, 8(2), 41-46. doi: 10.11648/j.ajbls.20200802.13

Copy | Download

AMA Style

Ying Wu, Bin Pan, Yutong Li, Jinai He, Guohua Huang, et al. Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. Am J Biomed Life Sci. 2020;8(2):41-46. doi: 10.11648/j.ajbls.20200802.13

Copy | Download

@article{10.11648/j.ajbls.20200802.13,
  author = {Ying Wu and Bin Pan and Yutong Li and Jinai He and Guohua Huang and Qiufeng Li},
  title = {Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China},
  journal = {American Journal of Biomedical and Life Sciences},
  volume = {8},
  number = {2},
  pages = {41-46},
  doi = {10.11648/j.ajbls.20200802.13},
  url = {https://doi.org/10.11648/j.ajbls.20200802.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20200802.13},
  abstract = {At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China
AU  - Ying Wu
AU  - Bin Pan
AU  - Yutong Li
AU  - Jinai He
AU  - Guohua Huang
AU  - Qiufeng Li
Y1  - 2020/04/23
PY  - 2020
N1  - https://doi.org/10.11648/j.ajbls.20200802.13
DO  - 10.11648/j.ajbls.20200802.13
T2  - American Journal of Biomedical and Life Sciences
JF  - American Journal of Biomedical and Life Sciences
JO  - American Journal of Biomedical and Life Sciences
SP  - 41
EP  - 46
PB  - Science Publishing Group
SN  - 2330-880X
UR  - https://doi.org/10.11648/j.ajbls.20200802.13
AB  - At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.
VL  - 8
IS  - 2
ER  -

Copy | Download

Author Information

Ying Wu

Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Bin Pan

Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Yutong Li

Department of Urology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Jinai He

Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Guohua Huang

Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China
Qiufeng Li

Department of Nursing, The First Affiliated Hospital of Jinan University, Guangzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Ying Wu, Bin Pan, Yutong Li, Jinai He, Guohua Huang, et al. (2020). Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. American Journal of Biomedical and Life Sciences, 8(2), 41-46. https://doi.org/10.11648/j.ajbls.20200802.13

Copy | Download

ACS Style

Ying Wu; Bin Pan; Yutong Li; Jinai He; Guohua Huang, et al. Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. Am. J. Biomed. Life Sci. 2020, 8(2), 41-46. doi: 10.11648/j.ajbls.20200802.13

Copy | Download

AMA Style

Ying Wu, Bin Pan, Yutong Li, Jinai He, Guohua Huang, et al. Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China. Am J Biomed Life Sci. 2020;8(2):41-46. doi: 10.11648/j.ajbls.20200802.13

Copy | Download

@article{10.11648/j.ajbls.20200802.13,
  author = {Ying Wu and Bin Pan and Yutong Li and Jinai He and Guohua Huang and Qiufeng Li},
  title = {Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China},
  journal = {American Journal of Biomedical and Life Sciences},
  volume = {8},
  number = {2},
  pages = {41-46},
  doi = {10.11648/j.ajbls.20200802.13},
  url = {https://doi.org/10.11648/j.ajbls.20200802.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20200802.13},
  abstract = {At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Strategic Analysis of COVID-19 Response Measures and Psychological Intervention in China
AU  - Ying Wu
AU  - Bin Pan
AU  - Yutong Li
AU  - Jinai He
AU  - Guohua Huang
AU  - Qiufeng Li
Y1  - 2020/04/23
PY  - 2020
N1  - https://doi.org/10.11648/j.ajbls.20200802.13
DO  - 10.11648/j.ajbls.20200802.13
T2  - American Journal of Biomedical and Life Sciences
JF  - American Journal of Biomedical and Life Sciences
JO  - American Journal of Biomedical and Life Sciences
SP  - 41
EP  - 46
PB  - Science Publishing Group
SN  - 2330-880X
UR  - https://doi.org/10.11648/j.ajbls.20200802.13
AB  - At the end of 2019, an ongoing outbreak of novel Corona Virus Disease 2019 (COVID-19) was first found in Wuhan, China with a sign of person-to-person transmission and city-to-city transmission, and has spread globally. At present, the COVID-19 mortality rate in China is 2.3%, while the SARS was 9.6% and the MERS was 34.4%, reported by WHO. China improved the surveillance network when the outbreak occurred and the labs promptly identified and shared the coronavirus genome that has served greatly to effective epidemic control. Given the fact that the number of infections in China is gradually declining while that outside of China keeps rising, more comprehensive information about the features, origin, epidemiology, clinical spectrum of COVID-19 is to be identified by further studies. The analysis of Chinese WHO-affirmed effective prevention and control strategies will help China and the rest of the world better contain this outbreak and end it as soon as possible. At present, effective prevention measures for COVID-19 include isolating the infectious agents, curbing the route of transmission, conducting health education to citizens, making fewer trips outside, washing hands frequently, wearing masks, protecting eyes, showing more understanding and consolation to patients, especially to elderly patients, providing mental support for medical staff and employing y psychological intervention timely.
VL  - 8
IS  - 2
ER  -

Copy | Download